Presented by: Russell Jaffe, MD, PhD, CNN
Recorded: June 2017
An epidemic of chronic disease threatens to compromise the health of our population and the effectiveness and economics of our healthcare system. The current medical model fails to confront both causes and solutions for the chronic disease epidemic. Clinicians have thousands of lab tests to choose from, but which ones can predict 10 year survival and quality of life? In this webinar, functional medicine pioneer, Dr. Russell Jaffe, reviews 8 tests that reveal health risk years to decades before disease occurs.
Join us to better understand why these Predictive Biomarker tests are the foundation of personalized, proactive disease prevention.
Russ Jaffe is Founder and Chairman of PERQUE Integrative Health, LLC (PIH, www.PERQUE.com) a company that offers the world scientifically proven, integrative health solutions to help speed the transition from sick care to healthful caring.
Dr. Jaffe has more than 40 years of experience contributing to molecular biology and clinical diagnostics. His focus is on functional, predictive tests and procedures designed to improve the precision of both diagnosis and of treatment outcomes and he has authored nearly 100 articles on the subject. He received his B.S., MD and Ph.D. from the Boston University School of Medicine, completed residency training in clinical chemistry at the National Institutes of Health and remained on the permanent senior staff before pursuing other interests, including starting the Health Studies Collegium think tank.
Dr. Jaffe is board certified in Clinical Pathology and in Chemical Pathology. He is the recipient of the Merck, Sharp & Dohm Excellence in Research Award, the J.D. Lane Award, and the U.S.P.H.S. Meritorious Service Award. Dr Jaffe was honored as an International Scientist of 2003 by the IBC, Oxford, England, UK for his lifetime contributions to clinical medicine, biochemistry, immunology, methodology, and integrative health policy. He is widely published and sought to explain complex subjects to any audience. Dr. Jaffe is also founder and chairman of ELISA/ACT Biotechnologies, and MAGique BioTherapeutics.